Did you know?

Complete Editas Medicine Inc. stock information by Barron's. View real-time EDIT stock price and news, along with industry-best analysis.View Editas Medicine, Inc EDIT investment & stock information. Get the latest Editas Medicine, Inc EDIT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Get Editas Medicine Inc (EDIT.OQ) real-time stock quotes, news, ... Editas Medicine, Inc. is a clinical-stage genome editing company.Jan 9, 2023 · Shares of Editas Medicine ( EDIT 2.28%) are sliding today, down by 7.2% as of 11:26 a.m. ET. The decline came after the company announced a big shake-up with its research and development focus ... The Editas Medicine management team will host a conference call and webcast today at 8:00 a.m. ET to provide and discuss a corporate update and financial results for the first quarter of 2023. To ...The Editas Medicine stock forecast for tomorrow is $ 10.59, which would represent a 0.59% gain compared to the current price. In the next week, the price of EDIT is expected to decrease by -23.77% and hit $ 8.03. As far as the long-term Editas Medicine stock forecast is concerned, here’s what our predictions are currently suggesting.The Editas Medicine stock prediction results are shown below and presented as a graph, table and text information. Editas Medicine stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Editas Medicine analysts is $ 13.53. Today 200 Day Moving Average is …CAMBRIDGE, Mass., June 14, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that it intends to offer and sell $125 million of shares of its common stock in an underwritten public offering. Editas Medicine intends to grant the underwriters a 30-day option to …Editas Medicine, Inc. Common Stock (EDIT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing.The analyst also gave the stock a price target of $20. Editas Medicine's share price as of the closing of business day yesterday was $40.98. And even after today's sell-off, Editas Medicine stock ...Editas Medicine (EDIT 0.86%) sits at the bleeding edge of biotech's hottest field, gene editing to treat inherited diseases. The company has shifted its focus to a product it is testing for severe ...Editas Medicine: 3 Positives To Cling To In 2023 (And Why They May Not Be So Positive) Dec. 06, 2022 2:33 PM ET Editas Medicine, Inc. (EDIT) 1 Comment 6 Likes. ... Editas stock is down 66%. Is ...Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing. Lastly, Caribou Biosciences, Prime Medicine, and Editas Medicine are all worth owning as a hedge against the highly uncertain nature of the field's long-term future.Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing.Editas Medicine intends to grant the underwriters a 30-day option to purchase up to an additional 525,000 shares of its common stock. All of the shares in the offering are to be sold by Editas ...Editas Medicine Inc stock price live 10.42, this page displays NASDAQ EDIT stock exchange data. View the EDIT premarket stock price ahead of the market session or assess the after hours quote.Find out the direct holders, institutional holders and mutual fund holders for Editas Medicine, Inc. (EDIT). Another Jennifer Doudna co-founded company is Editas Medicine (NASDAQ: EDIT). Like Intellia, Editas is among the gene editing stocks using CRISPR/Cas9 systems to to solve incurable diseases.Editas Medicine works with two distinct CRISPR nucleases: Cas9 and Cas12a (also known as Cpf1). Both nucleases have distinct gene editing and targeting capabilities. Using these two nucleases, we can access a broad range of genetic mutations and develop targeted and durable gene edited medicines. We are researching and developing two types of ... The Editas Medicine, Inc stock price gained 0.86% on the last trading day (Friday, 24th Nov 2023), rising from $10.49 to $10.58. During the last trading day the stock fluctuated 3.71% from a day low at $10.50 to a day high of $10.89. The price has risen in 6 of the last 10 days and is up by 34.43% over the past 2 weeks.Editas Medicine (NASDAQ: EDIT), a genome-editing company, has seen a significant 20% surge in its stock, marking its largest increase over two years.This comes despite a 4.9% dip year-to-date and ...Name. Chg %. Market Cap. Molecular Templates Inc. 2.25%. $26.23M. EDSep 30, 2020 · Current Price. $10.65. Price as o Nov 8, 2021 · Shares of Editas Medicine ( EDIT 11.39%) were jumping 9.4% as of 12:27 p.m. EST on Monday. The gain came after the company provided its third-quarter update earlier in the day. Editas reported ... Editas Medicine, Inc. Common Stock (EDIT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Editas Medicine has granted the underwriters a 30-day option to purc US$262,437,000 (2019) Number of employees. 208 [2] (2020) Website. www .editasmedicine .com. Editas Medicine, Inc., (formerly Gengine, Inc. ), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. [3] [4] Editas headquarters is located in Cambridge, Massachusetts and ... Top Performers. Earnings Gainers. Earnings Stalwarts. Safe (er) Stock

Editas Medicine, Inc. Common Stock (EDIT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Editas Medicine Stock Forecast 11-26-2023. Forecast target price for 11-26-2023: $ 10.97. Positive dynamics for Editas Medicine shares will prevail with possible volatility of 3.528%. Pessimistic target level: 10.80. Optimistic target level: 11.19.In addition, Editas Medicine, Inc. has a VGM Score of D (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style ...In the last 3 months, 6 analysts have offered 12-month price targets for Editas Medicine. The company has an average price target of $14.67 with a high of $22.00 and a low of $8.00.

This week was a significant bounce back after Editas' shares stumbled following an announcement by the company on Jan. 9 that it was suspending some of its programs and cutting about 20% of its ...Still, Editas makes a reasonable case for best short-squeeze stocks because of the possibility of medical breakthroughs. Just in the open market alone, biotech shares can skyrocket in the blink of ...Conference Call The Editas Medicine management team will host a conference call and webcast today at 8:00 a.m. ET to provide and discuss a corporate update and financial results for the third quarter of 2023. To access the call, please dial 1-877-407-0989 (domestic) or 1-201-389-0921 (international) and ask for the Editas ……

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. The Editas Medicine management team will host a conference call and. Possible cause: Stock Quote. Change Volume 52 Week High 52 Week Low Dec 2, 2023 5:42 PM EST. ... .